Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
01 2021
Historique:
received: 19 06 2020
revised: 27 08 2020
accepted: 30 08 2020
pubmed: 11 10 2020
medline: 9 2 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Familial Mediterranean fever (FMF) is the most frequent hereditary autoinflammatory disease. Its diagnosis relies on a set of clinical criteria and a genetic confirmation on identification of biallelic pathogenic Real-time pyroptosis and IL-1β secretion were monitored in response to UCN-01 in monocytes from FMF patients (n=67), HD (n=71) and OID patients (n=40). Sensitivity and specificity of the resulting diagnostic tests were determined by receiver operating characteristic curve analyses. Inflammasome monitoring in response to UCN-01 discriminates FMF patients from other individuals. Pyroptosis assessment leads to a fast FMF diagnosis while combining pyroptosis and IL-1β dosage renders UCN-01-based assays highly sensitive and specific. UCN-01-triggered monocytes responses were influenced by UCN-01-based inflammasome assays could be used to rapidly diagnose FMF, with high sensitivity and specificity.

Sections du résumé

BACKGROUND AND OBJECTIVE
Familial Mediterranean fever (FMF) is the most frequent hereditary autoinflammatory disease. Its diagnosis relies on a set of clinical criteria and a genetic confirmation on identification of biallelic pathogenic
METHODS
Real-time pyroptosis and IL-1β secretion were monitored in response to UCN-01 in monocytes from FMF patients (n=67), HD (n=71) and OID patients (n=40). Sensitivity and specificity of the resulting diagnostic tests were determined by receiver operating characteristic curve analyses.
RESULTS
Inflammasome monitoring in response to UCN-01 discriminates FMF patients from other individuals. Pyroptosis assessment leads to a fast FMF diagnosis while combining pyroptosis and IL-1β dosage renders UCN-01-based assays highly sensitive and specific. UCN-01-triggered monocytes responses were influenced by
CONCLUSIONS
UCN-01-based inflammasome assays could be used to rapidly diagnose FMF, with high sensitivity and specificity.

Identifiants

pubmed: 33037005
pii: annrheumdis-2020-218366
doi: 10.1136/annrheumdis-2020-218366
doi:

Substances chimiques

IL1B protein, human 0
Inflammasomes 0
Interleukin-1beta 0
MEFV protein, human 0
Protein Kinase Inhibitors 0
Pyrin 0
7-hydroxystaurosporine 7BU5H4V94A
Staurosporine H88EPA0A3N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-132

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: YJ, FM, AB, AM and TH are coinventors and owners of a patent 'Methods and kits for diagnosis of familial Mediterranean fever' (WO/2019/048569).

Auteurs

Flora Magnotti (F)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France.

Tiphaine Malsot (T)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France.

Sophie Georgin-Lavialle (S)

Internal Medicine, Tenon Hospital, AP-HP, Paris, France.
CEREMAIA (Centre de Référence des Maladies Autoinflammatoires et des Amyloses), Paris, France.

Fatima Abbas (F)

Biostatistics, Pôle de Santé Publique,CNRS UMR5308, Hospices Civils de Lyon, Lyon, France.

Amandine Martin (A)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France.

Alexandre Belot (A)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France.
CEREMAIA (Centre de Référence des Maladies Autoinflammatoires et des Amyloses), Paris, France.
Department of Paediatric Nephrology, Rheumatology, Dermatology, Hôpital Femme-Mère Enfant, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Bron, France.

Maxime Fauter (M)

Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Internal Medicine, Hospices Civils de Lyon, Lyon, France.

Muriel Rabilloud (M)

Biostatistics, Pôle de Santé Publique,CNRS UMR5308, Hospices Civils de Lyon, Lyon, France.

Mathieu Gerfaud-Valentin (M)

Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.

Pascal Sève (P)

Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.

Agnes Duquesne (A)

Department of Paediatric Nephrology, Rheumatology, Dermatology, Hôpital Femme-Mère Enfant, Université Claude Bernard-Lyon 1, Hospices Civils de Lyon, Bron, France.

Arnaud Hot (A)

Internal Medicine, University Hospital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Stephane Durupt (S)

Internal Medicine, University Hospital Lyon Sud, Hospices Civils de Lyon, Lyon, France.

Léa Savey (L)

Internal Medicine, Tenon Hospital, AP-HP, Paris, France.

Irina Giurgea (I)

Genetics, Armand-Trousseau Hospital, APHP, Sorbonne University, Paris, Île-de-France, France.

Gilles Grateau (G)

Internal Medicine, Tenon Hospital, AP-HP, Paris, France.
CEREMAIA (Centre de Référence des Maladies Autoinflammatoires et des Amyloses), Paris, France.

Thomas Henry (T)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France.

Yvan Jamilloux (Y)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, Ecole Normale Supérieure de Lyon, Lyon, France yvan.jamilloux@chu-lyon.fr.
Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH